Loading...
Price History
Market Data
| Market Cap | 20.99B |
| P/E Ratio | 21.99 |
| P/B Ratio | 2.89 |
| EPS | 8.52 |
| Dividend Yield | 0.96% |
| D/E Ratio | - |
| Current Ratio | 1.13 |
| Currency | USD |
Key Financial Metrics
10.85B
Revenue
969.00M
Net Income
8.52
EPS (Diluted)
2.22B
Free Cash Flow
Profitability
Gross Margin
33.3%
Operating Margin
14.1%
Net Profit Margin
8.9%
EBITDA
2.23B
Returns & Efficiency
Return on Assets (ROA)
6.0%
Return on Equity (ROE)
13.4%
Dividend Yield
0.96%
EPS
8.52
Financial Health
Total Assets
16.20B
Total Debt
5.17B
Debt to Equity
-
Current Ratio
1.13
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Health Services |
| HQ | SECAUCUS, NJ |
| Fiscal Year | 2024 |
Peers
NATERA, INC.
NTRA
27.86B
P/E: --
20.86B
P/E: --
20.86B
P/E: --
12.53B
P/E: --
12.53B
P/E: --
EXACT SCIENCES CORP
EXAS
9.06B
P/E: --
CELCUITY INC.
CELC
6.33B
P/E: --
RADNET, INC.
RDNT
4.54B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$20.99B
P/E Ratio (TTM)22.0
Price to Book2.89
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin33.3%
Operating Margin14.1%
Net Margin8.9%
ROE13.4%
ROA6.0%
Leverage & Liquidity
Debt to Equity-
Current Ratio1.13
Total Debt$5.17B
Total Assets$16.20B
Stockholders' Equity$7.26B
Income Statement (FY 2024)
Revenue$10.85B
Gross Profit$3.61B
Operating Income$1.53B
Net Income$969.00M
EPS (Diluted)$8.52
Cash Flow (FY 2024)
Free Cash Flow$2.22B
Cash & Equivalents$432.00M
Revenue Growth-
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 500 PLAZA DRIVE SECAUCUS, NJ 07094 |
| Phone | 9735202700 |
| Incorporated | DE, US |
| EIN | 161387862 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 112.00M |
| Stockholders' Equity | $7.26B |
| Cash & Equivalents | $432.00M |
Recent Filings
View All
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-30
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
424B2
Prospectus (Rule 424b2)
Prospectus filed under Rule 424(b)(2)
Filed: 2026-04-28
Local
FWP
Free Writing Prospectus
Written communication re: securities offering
Filed: 2026-04-27
Local
424B2
Prospectus (Rule 424b2)
Prospectus filed under Rule 424(b)(2)
Filed: 2026-04-27
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-22
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-21
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-06
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
3
Initial Ownership Report
Initial statement of beneficial ownership of securities
Filed: 2026-03-11
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-05
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-05
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | QUEST DIAGNOSTICS INC |
| Ticker | DGX |
| Exchange | -- |
| Sector | Services |
| Industry | Health Services |
| Headquarters | SECAUCUS, NJ |
| Fiscal Year | 2024 |
Financial Summary
| Market Cap | 20.99B |
| Revenue | 10.85B |
| Net Income | 969.00M |
| P/E Ratio | 21.99 |
| EPS | 8.52 |
| Net Margin | 8.9% |
| ROE | 13.4% |
| Dividend Yield | 0.96% |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...